Publications by authors named "Maria Rafalski"

Claim this Profile
S
Synthesis and structure-activity relationships of pyrido[3,2-b]pyrazin-3(4H)-ones and pteridin-7(8H)-ones as corticotropin-releasing factor-1 receptor antagonists.
Carolyn D Dzierba, Thais M Sielecki, Argyrios G Arvanitis, Amy Galka, Tricia L Johnson, Maria Rafalski

Bioorg Med Chem Lett· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.
Zilun Hu, Xiangjun Jiang, Charles F Albright, Nilsa Graciani, Eddy Yue, Maria Rafalski

Bioorg Med Chem Lett· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists.
Richard A Hartz, Vijay T Ahuja, Maria Rafalski, William D Schmitz, Allison B Brenner

J Med Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists.
Richard A Hartz, Vijay T Ahuja, Argyrios G Arvanitis, Maria Rafalski, Eddy W Yue

J Med Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydropyridopyrazinones and dihydropteridinones as corticotropin-releasing factor-1 receptor antagonists: structure-activity relationships and computational modeling.
Carolyn D Dzierba, Andrew J Tebben, Richard G Wilde, Amy G Takvorian, Maria Rafalski

J Med Chem· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity.
Charles F Albright, Nilsa Graciani, Wei Han, Eddy Yue, Ross Stein, Maria Rafalski

Mol Cancer Ther· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, structure-activity relationships, and in vivo properties of 3,4-dihydro-1H-pyrido[2,3-b]pyrazin-2-ones as corticotropin-releasing factor-1 receptor antagonists.
Carolyn D Dzierba, Amy G Takvorian, Maria Rafalski, Padmaja Kasireddy-Polam, Harvey Wong

J Med Chem· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-arylation of primary and secondary aliphatic amines on solid supports.
Andrew P Combs, Seifu Tadesse, Maria Rafalski, Tasir S Haque, Patrick Y S Lam

J Comb Chem· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis